Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

VIR BIOTECHNOLOGY, INC.

(VIR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart VIR BIOTECHNOLOGY, INC.
Upcoming events on VIR BIOTECHNOLOGY, INC.
11/03/22 Q3 2022 Earnings Release (Projected)
02/23/23 FY 2022 Earnings Release (Projected)
05/04/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
Past events on VIR BIOTECHNOLOGY, INC.
09/13/22 | 04:05pm Morgan Stanley Global Healthcare Conference
08/09/22 | 04:02pm Interim 2022 Earnings Release
06/25/22 | 04:00am European association for the study of the liver international liver congress - abstract no : #654
06/25/22 | 04:00am European association for the study of the liver international liver congress - abstract no: #3009
06/25/22 | 03:00am European association for the study of the liver international liver congress - abstract no : #644
05/20/22 | 02:30pm Annual General Meeting
05/05/22 | 04:07pm Q1 2022 Earnings Release
04/27/22 | 12:00pm Investor Day
04/11/22 | 11:00am Needham Virtual Healthcare Conference
03/09/22 | 10:30am Cowen & Co. Health Care Conference
Past dividends on VIR BIOTECHNOLOGY, INC.

- No events available -

Annual results
Fiscal Period : December2019202020212022
Sales
M $
Released
Forecast
Spread
8,09
9,15
-12%
76,4
79,3
-3,7%
1 095
906
21%
 
1 373
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-173
-191
9,4%
-292
-274
-6,4%
427
664
-36%
 
822
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-178
-196
9,1%
-297
-280
-6,2%
421
275
53%
 
626
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-175
-193
9,4%
-299
-285
-4,7%
550
463
19%
 
560
 
Net income
M $
Released
Forecast
Spread
-175
-193
9,3%
-299
-284
-5,1%
529
365
45%
 
350
 
EPS
$
Released
Forecast
Spread
-5,76
-2,77
-108%
-2,51
-2,38
-5,3%
3,96
2,74
44%
 
2,57
 
Announcement Date03/26/202002/25/202102/24/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
177
84,6
109%
104
138
-25%
813
623
30%
1 232
811
52%
-40,6
211
-119%
 
101
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
62,3
-48,4
229%
-52,0
-11,7
-345%
573
958
-40%
1 015
369
175%
-224
12,3
-1 920%
 
237
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
61,0
-51,4
219%
-53,4
1,30
-4 215%
572
419
37%
1 014
546
86%
-225
69,1
-426%
 
-71,2
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
61,9
-39,5
257%
111
15,5
617%
546
450
21%
922
588
57%
-234
109
-314%
 
-37,4
 
Net income
M $
Released
Forecast
Spread
61,8
-49,8
224%
110
12,8
764%
525
353
49%
519
475
9,3%
-76,5
76,4
-200%
 
-3,32
 
EPS
$
Released
Forecast
Spread
0,46
-0,41
212%
0,82
0,08
874%
3,92
2,63
49%
3,85
3,54
8,8%
-0,58
0,26
-324%
 
-0,02
 
Announcement Date08/05/202111/04/202102/24/202205/05/202208/09/2022-
Previous year Next Year
Upcoming sector events for VIR BIOTECHNOLOGY, INC.
More events
Past sector events for VIR BIOTECHNOLOGY, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise